The Proteomic Landscape of Triple Negative Breast Cancer

Cell lines: 20
Tumors: 4
Proteins: 11,343

This resource is comprised of deep proteome profiles of breast cancer cell lines and tissues acquired using liquid chromatography tandem mass spectrometry (LC-MS/MS).

It is presented here in the context of cellular subtype, mutational status, and drug sensitivity.

Please cite: Lawrence RT et al. The proteomic landscape of triple-negative breast cancer. (2015) Cell Reports 11, 1-15.
The research was supported by Howard Temin Pathway to Independence Award K99/R00 from NIH/NCI (R00CA140789)